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Abstract
Aims: During pregnancy, the placenta produces a variety
of steroid hormones and proteins. Several of these sub-
stances have been shown to exert immunomodulatory
effects. Progesterone is thought to mediate some of
these effects by regulating uterine responsiveness. The
aim of this study was to clarify the effect of amniotic fluid
transferrin and its N-glycans on the release of proges-
terone by first trimester trophoblast cells in vitro.
Methods: Cytotrophoblast cells were prepared from
human first trimester placentae by trypsin-DNAse dis-
persion of villous tissue followed by a percoll gradient
centrifugation and depletion of CD45 positive cells by
magnetic cell sorting. Trophoblasts were incubated with
varying concentrations (50–300 mg/ml) of transferrin from
human amniotic fluid and serum as well as with N-gly-
cans obtained from amniotic fluid transferrin. Culture
supernatants were assayed for progesterone by enzyme-
immunometric methods.
Results: The release of progesterone increased in amni-
otic fluid transferrin- and N-glycan-treated trophoblast
cell cultures compared to untreated trophoblast cells.
There was no stimulating effect of serum transferrin on
the progesterone production of trophoblast cells.
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Conclusions: The results suggest that amnion-transfer-
rin and especially its N-glycans modulate the endocrine
function of trophoblasts in culture by up regulating pro-
gesterone secretion.
Keywords: N-glycans; progesterone production; trans-
ferrin; trophoblast cells.
Introduction
During pregnancy the immune response of the mother
against certain antigens is reduced w5, 8x. One molecule
out of a variety that regulate uterine immune responsive-
ness is progesterone w1, 7x. Siiteri et al. w18x found that
progesterone inhibits the inflammatory response. The
suppression of mixed lymphocyte culture responses by
progesterone has been also described w2x. Due to its lipid
solubility, progesterone incorporates into the lymphocyte
plasma membrane interfering with membrane dynamics.
This promotes a locally suppressed activity at the mater-
nal-fetal frontier.
In most mammals, progesterone production is initially
located in the corpus luteum of the ovary, shifting to the
trophoblast as pregnancy proceeds. Progesterone bio-
synthesis in the human placenta is regulated by a variety
of hormones. Progesterone synthesis is also regulated by
estradiol-17-beta and auto regulated by progesterone w7x
itself. Feinberg et al. w6x showed that progesterone pro-
duction was significantly stimulated by interleukin-1
alpha (IL-1 a), interleukin-1 beta (IL-1 b) and tumor-
necrosis-factor-alpha (TNF-a) in chorion carcinoma cells.
In addition, progesterone plays also a role in mainte-
nance of pregnancy. New results of Meis et al. w15x and
da Fonseca et al. w4x show that administration of pro-
gesterone is able to prevent preterm delivery.
During gestation, the fetus requires large amounts of
iron. The major iron source is maternal holo-serum trans-
ferrin w19, 22x. Transferrin-dependent iron transfer is
mediated by transferrin receptors, which are present on
the maternal-facing plasma membrane and on the fetal-
facing basal plasma membrane of placental syncytiotro-
phoblasts w11, 22x.
Transferrin is present in amniotic fluid in relatively high
concentrations, showing a different glycosylation com-
pared with serum transferrin w20x. The biological function
of human amniotic fluid transferrin (hAFT) is still
unknown. In addition, trophoblast cells also synthesize
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Figure 1 Isolated trophoblast cells express cytokeratin 7 as a
specific marker for trophoblast tissue detected with monoclonal
mouse antibodies of the IgG subtype and staining with fast red;
40=lens.
Figure 2 Isolated trophoblast cells also produce hCG detected
in the cytoplasma of trophoblasts with polyclonal rabbit anti-
bodies and staining with the fast red reagent; 40=lens.
transferrin w24x, which shows a special glycosylation pat-
tern w21x. We found identical carbohydrate structures of
hAFT and trophoblast transferrin w20, 21x. In this study,
we investigated the influence of hAFT and its N-glycans
on the release of progesterone of first trimester tropho-
blast cells in vitro.
Material and methods
Purification of transferrin from amniotic fluid
Human amniotic fluid was dialyzed against 50 mmol/l NH4HCO3
buffer, pH 8.3 and fractionated on a DEAE-Sepharose CL-6B
column (5=15 cm; Pharmacia, Uppsala, Sweden). The material
was further purified on a Superdex 75 column (1.6=60 cm;
Pharmacia). Buffer exchange was performed on a Sephadex G
25 column equilibrated with 50 mmol/l Tris-HCl, pH 7.2. Sub-
sequently, transferrin-containing material was applied to a pro-
tein A column (2=1 ml, Pharmacia), equilibrated with 20 mmol/
l NaH2PO4, pH 7.0 to remove remaining IgG. The elution was
performed isocratically at a flow rate of 1 ml/min. The main frac-
tion containing transferrin was pooled and used for the final puri-
fication. Monoclonal antibodies directed against human
chorionic gonadotropin (1 mg, IgG1, clone 816, Dianova, Ham-
burg, Germany) were coupled to CNBr-Sepharose 4B (1 ml,
Pharmacia). After blocking the remaining active groups with gly-
cine, the material was loaded on a column and equilibrated with
20 mmol/l NaH2PO4, pH 7.0. The transferrin containing material
was then applied to the column and eluted at a flow rate of 1 ml/
min. The main fraction containing pure amniotic fluid transferrin
was concentrated by ultra filtration (PM 10 membrane, Amicon).
The purity was checked by SDS-PAGE and N-terminal amino
acid analysis. Quantification of the isolated transferrin was per-
formed on a VITROS 250 analyzer (Ortho-Clinical Diagnostics
GmbH, Neckargemu¨nd, Germany).
Preparation of hAFT-N-glycan-Asn
Purified and lyophilized human amniotic fluid transferrin (111 mg)
was dissolved in 1.5 ml of 15 mmol/l CaCl2 buffer containing
1.5 mmol of NaN3. To the solution were added 2.2 mg of pro-
tease type XIV from Streptomyces griseus (Sigma), pH was
adjusted to 8.5 and the mixture was incubated at room temper-
ature for three days. After removal of the precipitate by centrif-
ugation, the supernatant was lyophilized and purified by
gelfiltration on a Hi Load Superdex 30 column (1.6=600 cm,
Pharmacia), equilibrated and eluted with 100 mmol/l NH4HCO3
buffer at a flow rate of 750 ml/min (detection: 214 and 254 nm).
Carbohydrate-containing fractions were analyzed by TLC (1 mol/
l ammonium acetate: isopropanols1:2) and detected with a 1:1
mixture of 1 mol/l H2SO4 and 0.2% resorcine monomethylether
in ethanol. The pooled fractions were lyophilized and the remain-
der (11.7 mg) was dissolved in 150 ml of 15 mmol/l CaCl2 buffer
containing 1.5 mmol of NaN3. To the solution were added
0.22 mg of protease type XIV from Streptomyces griseus (Sig-
ma), the pH was adjusted to 8.5 and the mixture was incubated
at room temperature for three days. The reaction mixture was
purified on a Hi Load Superdex 30 column (1.6=600 cm, Phar-
macia), equilibrated and eluted with 100 mmol/l NH4HCO3 buffer
at a flow rate of 750 ml/min (detection: 214 and 254 nm). The
fractions (4 ml) eluting between 77 and 95 min were lyophilized,
analyzed by 500 MHz-1H-NMR and pooled. Yield: 5.14 mg
(4.6%); Rfs0.08–0.13 (1 mol/l ammonium acetate: iso-
propanols1:2).
Culture of first trimester trophoblast cells
Trophoblast cells were isolated from four different human first
trimester placentas obtained after legal abortion. Tissue dis-
sected from the placenta was minced and transferred to HBSS-
HEPES-buffer containing trypsin (10000–13000 U/mg) and
DNAse I (0.1 mg/ml). The cell suspensions obtained by three
digestion steps were separated from tissue fragments. The first
step of throphoblast cell purification was performed on a Percoll
(Pharmacia) gradient w9, 12x. Trophoblast cells collected at the
interphase were removed, washed, and incubated with an anti-
CD45 monoclonal antibody (Dianova, Hamburg, Germany) fol-
lowed by rat anti-mouse magnetic MicroBeads (Miltenyi Biotec,
Bergisch-Gladbach, Germany). For the depletion of leukocytes,
cells were applied to a MiniMACS column (Miltenyi Biotec), and
purified trophoblast cells were obtained w10x. Trophoblast iden-
tity of the isolated cells was determined morphologically by light
microscopy, by their ability to produce specific hormones (hCG,
progesterone, hPL), and by immunostaining with a monoclonal
mouse anti-cytokeratin 7 antibody (Progen Biotechnik, Heidel-
berg, Germany) (Figure 1) and a polyclonal rabbit anti hCG anti-
body (Dako, Hamburg, Germany) (Figure 2). Isolated cells were
CD45 negative (Figure 3) whereas depleted leucocytes showed
a strong CD45 staining (Figure 4). Trophoblast cells were cul-
tured in DMEM medium with 10% inactivated fetal calf serum
and with antibiotics and antimycotics.
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Figure 3 Isolated trophoblast cells after purification with mag-
netic cell sorting are negative for CD45 (incubation with a mono-
clonal mouse anti CD 45 antibody (IgG) and staining with fast
red); 10=lens.
Figure 4 Expression of CD45 is shown in depleted placental
immune cells after magnetic cell sorting and incubation with a
monoclonal mouse anti CD 45 antibody (IgG) and staining with
fast red; 10=lens.
Table 1 Antibodies used in this study.
Antigen Antibody Isotype Concentration/Dilution Source
CD 45 (LCA) CBL 124 Mouse IgG 1:100 Dianova
CK 7 Ks 7.18 Mouse IgG 1:50 Progen Biotechnik
hCG A 0231 Rabbit IgG Ready to use Dako
CKscytokeratin, LCAsleucocyte common antigen.
Immunocytochemistry
Isolated trophoblast cells were grown on 3-well multitest slides
(Roth, Karlsruhe, Germany) to subconfluency, dried, wrapped
and stored at y808C. After thawing, cells were briefly fixed with
formalin (Merck, Darmstadt, Germany, 5% in PBS, 5 min) and
permeabilized with digitonin (Ysat, Wernigerode, Germany, 6mg/
ml in PBS, 15 min). Both treatments do not interfere with binding
even in cases where epitopes are known to be sensitive to for-
malin w9x. Antibodies were diluted with cell culture medium and
incubated overnight at 48C. Antibodies used for the experiments
are listed in Table 1. After washing, slides were stained with the
Vectastain Elite ABC-Kit (Vector Laboratories, Borlingame, CA).
Visualization was performed with the Fast-Red reagent.
Treatment of trophoblast cultures with hAFT, serum
transferrin and N-glycan-Asn of hAFT
Purified first trimester trophoblasts were adjusted to a cell con-
centration of 1=106 cells/ml. Cell suspensions were incubated
in the presence of amnion-transferrin (100–200 mg/ml), human
apo-serum transferrin (200 mg/ml, Sigma-Aldrich Chemie
GmbH, Germany) or varying concentrations (100–300 mg/ml) of
N-glycan-Asn of hAFT. Untreated cell cultures of each placenta
were used as controls. The effect of transferrin on the secretion
of progesterone for syncytiotrophoblasts was studied by simul-
taneously comparing the kinetics of progesterone release of
untreated (controls) and transferrin-stimulated trophoblast cell
cultures. At designated times, aliquots of the culture media were
removed, frozen at y208C and replaced with fresh medium.
Cells were cultured for 8 and up to 72 hours.
Identification of secreted hormones
The secretion of progesterone was determined by means of the
analyzer SR1 from BioChemImmunoSystems GmbH. Progester-
one was analyzed by competitive enzyme immuno assay,
respectively. Specific antibodies were labeled with fluorescein.
After reaction with anti-fluorescein antibody and binding to mag-
netic particles the separation was performed. Color intensity
was measured at 3 different wave lengths. Samples were diluted
1:3 with hormone-free diluent because of the intensively colored
culture medium. Sensitivity and the intra-assay coefficient of
variation of progesterone EIA (-6.4 nmol/l and 6.8% at a medi-
um value of 11.5 nmol/l; 5.4% at 65.6 nmol/l, respectively) dem-
onstrate the accuracy of the applied methods.
Statistical analysis
Observations for the stimulation experiments at each sampling
time were compared using Wilcoxon’s signed rank tests. The
size of increase in progesterone levels after addition of the trans-
ferrins was compared using this test. Statistical computerization
of the analysis utilized the SPSS software package. P-0.05 was
considered statistically significant.
Results
Identification of hAFT and isolation of hAFT
N-glycans
hAFT was isolated from human amniotic fluid in a four-
step procedure using anion exchange chromatography
followed by gel filtration and immunoadsorption. The red-
dish-colored protein migrated similar to human serum
transferrin as a single band at 78 kDa in SDS-PAGE
under reducing conditions (Figure 5). Sequence analysis
of the first 6 N-terminal amino acids of amnion transferrin
revealed Val-Pro-Asp-Lys-Thr-Val, identical with the N-
terminal amino acid sequence of human serum transfer-
rin. The purified human amniotic fluid transferrin was
digested twice with a protease cocktail from Strepto-
myces griseus. This resulted in complete digestion of
transferrin to glycopeptides to respective N-glycan-
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Figure 5 SDS-polyacrylamide gel analysis of purified human
amnion fluid transferrin, reduced with 2-mercaptoethanol (Lane
1). Lane 2, molecular weight markers (numbers in kD). The gel
was stained with Coomassie blue.
Figure 6 Stimulation of progesterone production of isolated first trimester trophoblast cells induced by N-glycans of hAFT and for
comparison hAFT and serum transferrin. The cells (1=106/ml supplemented cell culture medium) were cultured for 8 and 72 hours
without (control), with 100 mg/ml, 200 mg/ml or with 300 mg/ml hAFT N-glycans or 100 and 200 mg/ml hAFT or 200 mg/ml serum
transferrin. Data represent the means"SD of four cultures, Asterisks represent significant differences between N-glycan stimulated
cultures and controls.
asparagines (N-glycan-Asn) as determined by 500 MHz-
1H-NMR. Only those fractions of N-glycans carrying
asparagine as the single amino acid were pooled and will
be referred to as N-glycan-Asn from hAFT.
Stimulation of progesterone production by human
amniotic-fluid-transferrin
To test the effect of hAFT on progesterone secretion of
trophoblast cells in vitro, we stimulated these cells with
increasing concentrations of amniotic fluid transferrin and
its N-glycans. In our experiments, trophoblast cells were
isolated from four different human first trimester placen-
tae. Analysis of progesterone in stimulated and unsti-
mulated cell cultures revealed that amnion trans-
ferrin-stimulated trophoblast cells and cells, which were
stimulated with N-glycans of hAFT, show a higher secre-
tion of progesterone compared to unstimulated cells over
a cultivation period of 72 h (Figure 6). There was a sig-
nificant difference between the progesterone production
of stimulated and unstimulated cell cultures (p-0.002 for
100 mg hAFT, p-0.002 for 200 mg hAFT and p-0.046
for 200 mg hAFT-N-glycan-Asn, p-0.028 for 300 mg/ml
hAFT N-glycan-Asn). The stimulation effect of hAFT and
its N-glycans is dose-dependent. Cells stimulated with
200 mg/ml hAFT showed the highest stimulation effects
compared to 100 mg/ml hAFT stimulated cells. Cells
stimulated with N-glycan-Asn from hAFT (300 mg/ml)
showed the highest stimulation rates compared to
200 mg/ml and 100 mg/ml N-glycan-Asn. Trophoblast
cells stimulated with serum-transferrin did not show an
increase in progesterone production as compared to
unstimulated controls.
Discussion
Our investigations show that especially the N-glycans of
human amniotic fluid transferrin (hAFT) stimulate the
secretion of progesterone in human first trimester tro-
phoblast cells in a time- and dose-dependent manner. In
a recent study w21x we found differences in the N-glycan
structures between hAFT and serum transferrin. Previ-
ously unknown (a1–3)-fucosylated N-glycans were
found, containing sialyl LeX motifs. Furthermore com-
pared to serum transferrin, a higher degree of (a1–6)-
fucosylation and an increase in branching from di- to
triantennary compounds has been detected. For the first
time the presence of O-glycans was described in trans-
ferrin. Recently Verrijt et al. w23x demonstrated that
human trophoblast cells isolated from term placentae
synthesize transferrin. This transferrin isolated from cyto-
trophoblast and syncytiotrophoblast cells was shown to
be different from both, maternal and fetal serum trans-
ferrin. The iso-electric points were found at lower pH
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compared to the iso-electric points of maternal and fetal
serum transferrin. A higher degree of sialylation and an
increase in branching was found in cytotrophoblast
transferrin. This is in agreement with our investigations
of the carbohydrate structures in hAFT, suggesting the
trophoblast origin of hAFT. Because the trophoblast is
able to produce transferrin with a special glycosylation,
we speculate that progesterone production in tropho-
blast cells can be stimulated by trophoblast produced
transferrin or in detail by its glycans in an auto- or par-
acrine mechanism.
The human placenta produces approximately 300 mg
of progesterone and about 100 mg of estrogens per day.
Progesterone facilitates the maintenance through a mul-
titude of mechanisms, e.g. by acting on the myometrium
and the uterine cervix. There is evidence that progester-
one has an immunosuppressive effect and can regulate
the cytokine network in the uterus w3x. Progesterone may
play an important role in the adaption of the maternal
cardiovascular system to pregnancy.
At the beginning of gestation, progesterone is synthe-
sized by the corpus luteum graviditatis and the tropho-
blast. Already in the 5th week of gestation, the trophoblast
becomes the main source for progesterone synthesis.
Biosynthesis of progesterone in the human placenta is
regulated by a number of substances. Feinberg et al. w6x
described that IL-1 a, IL-1 b and TNF a significantly
stimulated progesterone production of the trophoblast
tumor cell line JEG-3. Seki et al. w16x found that in pri-
mary placental cells, IL-1 beta had no effect on the pro-
gesterone production. Studies of Shanker et al. w17x with
first trimester or term human placental minces showed
that addition of estradiol-17-beta increased the proges-
terone production. Addition of the aromatase inhibitor
CGS 16949 A and the estrogen receptor antagonist ICI
182780 inhibited progesterone production. RU 486 and
ZK 98299, which are progesterone receptor antagonists,
significantly modulated progesterone synthesis. Shanker
et al. concluded that progesterone synthesis in human
placenta is regulated by estradiol-17-beta and autore-
gulated by progesterone itself. Osteogenic protein-1 (OP-
1/BMP-7), a member of the transforming growth factor
(TGF-b) superfamily of proteins, reduced the secretion of
progesterone in cytotrophoblast cultures of early and full
term placentas w14x. Results obtained in this study show
that progesterone synthesis during pregnancy is up reg-
ulated by trophoblast produced transferrin. In granulosa
cells on the other hand, transferrin inhibits progesterone
synthesis w11x. This result suggests that transferrin is able
to regulate progesterone synthesis in a variety of tissues.
During pregnancy however special glycosylated transfer-
rin up-regulates progesterone. This effect could be
important for the maintenance of pregnancy. As stated
by the studies of de Fonseca et al. and Meis et al. w4,
15x, administration of progesterone can prevent preterm
labor. On the basis of our results we may speculate that
also administration of special glycosylated transferrin
could be useful for prevention of preterm birth. This has
to be evaluated in larger studies.
In summary, this study provides evidence that N-gly-
can-Asn of hAFT, which differ from serum transferrin gly-
cans, are able to stimulate the progesterone secretion of
trophoblast cells in vitro. Because hAFT is produced by
trophoblast cells itself, an auto- or paracrine mechanism
of progesterone stimulation can be discussed.
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